Home LiteratureArticle Details
PMID: 1967386 Published · ppublish English Letter

Urokinase plasminogen activator and prognosis in breast cancer.

Lancet (London, England) ·Vol. 335 ·No. 8681 ·1990-01-13 ·Pages 108

Duffy MJ, Reilly D, O'Sullivan C, O'Higgins N, Fennelly JJ

Abstract

暂无摘要

MeSH Terms
Breast Neoplasms/mortality Female Fibrinolytic Agents/analysis Follow-Up Studies Humans Neoplasm Recurrence, Local/mortality Plasminogen Activators/analysis Prognosis Urokinase-Type Plasminogen Activator/analysis
Chemicals
Fibrinolytic Agents Plasminogen Activators Urokinase-Type Plasminogen Activator
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Duffy M J
Reilly D
O'Sullivan C
O'Higgins N
Fennelly J J
Article Info
Journal
Lancet (London, England)
Abbr.
Lancet
ISSN
0140-6736
DOI
10.1016/0140-6736(90)90571-l
Published
1990-01-13
Pages
108
Language
English
Region
England
NLM ID
2985213R
Subset
IM
External Links
PubMed source DOI: 10.1016/0140-6736(90)90571-l View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2